SYRA Stock Overview
A healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Syra Health Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.37 |
| 52 Week High | US$8.37 |
| 52 Week Low | US$0.81 |
| Beta | 0 |
| 1 Month Change | 31.47% |
| 3 Month Change | -35.07% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -54.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| SYRA | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -2.1% | -2.8% | -1.2% |
| 1Y | n/a | -1.4% | 21.5% |
Return vs Industry: Insufficient data to determine how SYRA performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how SYRA performed against the US Market.
Price Volatility
| SYRA volatility | |
|---|---|
| SYRA Average Weekly Movement | 22.5% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: SYRA's share price has been volatile over the past 3 months.
Volatility Over Time: SYRA's weekly volatility has decreased from 62% to 23% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 120 | Deepika Vuppalanchi | www.syrahealth.com |
Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States. The company Syrenity, behavioral and mental health application that identifies and prevents the progression of negative factors that can influence individuals’ mental health, by offering targeted assignments, education, monitoring symptoms, and providing interventions; digital health products, such as SyraBot that automates manual tasks to streamline healthcare professional care, aiding patients in identifying health warning signs, encouraging therapy and medical regimens, and space for patients to share personal information; and CarePlus, a customizable templates, e-prescribing, laboratory integration, and patient portal access. It offers analytics as a service which includes data collection, traditional to advanced analytics, predictive analytics, risk stratification, intervention analytics, spatial analytics gap analysis, analytics workforce public policy, and research; epidemiology, and health equity analytics solutions.
Syra Health Corp. Fundamentals Summary
| SYRA fundamental statistics | |
|---|---|
| Market cap | US$19.32m |
| Earnings (TTM) | -US$3.60m |
| Revenue (TTM) | US$6.08m |
3.2x
P/S Ratio-5.4x
P/E RatioIs SYRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SYRA income statement (TTM) | |
|---|---|
| Revenue | US$6.08m |
| Cost of Revenue | US$4.64m |
| Gross Profit | US$1.44m |
| Other Expenses | US$5.04m |
| Earnings | -US$3.60m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.26 |
| Gross Margin | 23.70% |
| Net Profit Margin | -59.21% |
| Debt/Equity Ratio | 2.9% |
How did SYRA perform over the long term?
See historical performance and comparison